French start-up Iktos announces a collaboration with Ono in artificial intelligence for new drug design

Rapid identification of molecules that simultaneously satisfy multiple parameters, such as potency, selectivity, safety, and project-specific properties

05-Apr-2022 - Iktos, a company specialized in Artificial Intelligence (AI) for new drug design announced a collaboration agreement with Ono Pharmaceuticals Co., Ltd., a leading pharmaceutical company based in Japan with a focus on innovative medicines dedicated to the fight against disease and pain. Under the ...

Merck Reaches Mutual Agreement with Ono Pharmaceutical to Terminate the License Agreement on Ceralifimod

18-Jun-2014 - Merck announced that it has reached a mutual agreement with Ono Pharmaceutical Co., Ltd., Osaka, Japan, to terminate the license agreement on ceralifimod (ONO-4641) because it does not meet Merck’s threshold for continued investment. Merck obtained worldwide exclusive license rights from Ono ...

Evotec achieves milestone in drug discovery collaboration with Ono

15-Jan-2013 - Evotec AG announced that a compound identified and optimised in a research collaboration with Ono Pharmaceutical Co., Ltd. has been nominated to enter pre-clinical development, leading to the payment of an agreed milestone. This collaboration project was initiated in March 2008. Evotec combined ...

Domain Therapeutics enters into collaboration agreement with Ono in the field of GPCR-based drug discovery

23-Oct-2012 - Domain Therapeutics S.A. announced that Domain Therapeutics and Ono Pharmaceutical Co., Ltd. (Osaka, Japan) signed a collaboration agreement focused on discovering small molecules targeting G-Protein Coupled Receptors (GPCRs).Under the agreement, Ono will provide Domain Therapeutics with an ...

Galapagos subsidiary BioFocus and Ono sign a drug discovery agreement in the Field of CNS Disorders

04-Sep-2012 - Galapagos NV announced that its service division BioFocus and Ono Pharmaceutical Co., Ltd. have signed a new collaboration agreement, focused on discovering novel drugs in the field of CNS disorders. Under the new agreement, BioFocus will use its drug discovery platform to deliver leads and ...

Merck and Ono Pharmaceutical Form Collaborations to Develop Oral Multiple Sclerosis Drug and Cancer Immunotherapy

06-Oct-2011 - Merck KGaA announced that it signed two agreements for collaboration of its Merck Serono division with Ono Pharmaceutical Co., Ltd., Osaka, Japan to strengthen its multiple sclerosis and cancer franchises. The first agreement grants Merck worldwide exclusive license rights for the development and ...

Evotec Achieves Milestone in an Ion Channel Drug Discovery Collaboration with Ono Pharmaceutical Co., Ltd.

Evotec receives a milestone payment from Ono for the progression of novel ion channel modulators into lead optimization

06-Jul-2011 - Evotec AG announced the achievement of specific success criteria in an ion channel research collaboration with Ono Pharmaceutical Co., Ltd. (Ono) and the receipt of a milestone payment. This collaboration project was initiated in October 2009 to identify small molecules targeting an ion channel ...

Ono and Galapagos subsidiary BioFocus sign target discovery agreement in the field of autoimmune disease

13-Jan-2011 - Ono Pharmaceutical Co., Ltd. and BioFocus announced that they have signed a collaboration agreement, focused on discovering novel targets in the field of autoimmune disease. Under the agreement, BioFocus will receive research funding and success payments based on the progress of the ...

Evotec Achieves Milestone in Medicinal Chemistry Collaboration with Ono Pharmaceutical Co., Ltd.

Evotec receives milestone from Ono for the progression of novel protease inhibitors into lead optimisation

16-Dec-2009 - Evotec AG announced that it has received a milestone payment from Ono Pharmaceutical Co., Ltd. (Ono) from its research collaboration aimed at identifying novel inhibitors for a protease target. The milestone is received for the progression of the medicinal chemistry collaboration into lead ...

Evotec Extends Medicinal Chemistry Collaboration with Ono Pharmaceutical

16-Oct-2009 - Evotec AG announced that it has extended its current research collaboration with Ono Pharmaceutical Co., Ltd. (Ono) and initiated a new discovery collaboration. Under the contract extension Evotec will provide integrated drug discovery activities, including high throughput screening, medicinal ...